Navigation Links
Cardio3 BioSciences Completes Patient Enrolment in First Stage of Pivotal Trial of C-Cure(R) in Heart Failure
Date:12/15/2009

MONT-SAINT-GUIBERT, Belgium, December 15 /PRNewswire/ --

- 45 Patients Enrolled in Study Designed to Evaluate the Ability of Cardiopoietic Cells to Restore Cardiac Function

Cardio3 BioSciences, a leading Belgian biotechnology company specialising in cell-based therapies for the treatment of cardiovascular diseases, announced today that it has completed, two months ahead of schedule, enrolment in the first stage of its pivotal Phase II/III trial of C-Cure, a unique stem cell therapy for heart failure. Forty-five patients have now enrolled in the study which is being conducted at centres in Belgium and Serbia. The C-Cure trial will ultimately enroll 240 patients making it one of the largest randomized trials in regenerative therapies for heart failure.

C-Cure is produced by taking a patient's own bone marrow cells and, through a proprietary process, differentiating them into cardiopoietic cells that can regenerate damaged heart muscle. The cardiopoietic cells are injected into the heart of a patient with heart failure where they are designed to behave identically to those cells lost in heart failure without carrying the risk of rejection, something that has not been achieved with previous cell therapies for this indication. C-Cure is the outcome of multiple years of research conducted at Mayo Clinic (Rochester, Minnesota, USA) and at the Cardiovascular Center in Aalst (Aalst, Belgium).

Safety data from this stage of the trial is expected to be available in May 2010. The second stage, which will recruit 195 further patients is expected to start in the third quarter of 2010 and involve further sites in Europe and in the United States. The trial design is a randomized, prospective, multi-center trial, to evaluate the safety and efficacy of C-Cure beyond optimal clinical care in patients with heart failure. The trial will also evaluate socio-economic implications of the
'/>"/>

SOURCE Cardio3 BioSciences
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Cardio3 BioSciences Presents Update on C-Cure(R) Second Generation Stem Cell Therapy for Heart Failure at European Society of Cardiology Congress
2. Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia
3. YM BIOSCIENCES OFFER FOR CYTOPIA APPROVED TO PROCEED TO SHAREHOLDER VOTE BY AUSTRALIAN COURT
4. YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES
5. Cell Biosciences Acquires Protein Forest
6. Merrimack Pharmaceuticals Acquires Hermes Biosciences, Inc.
7. Dow AgroSciences, Agrisoma Biosciences Announce Research and Commercial License Option Agreement for Agricultural Crops
8. Ardea Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference
9. YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA
10. American BioSciences Rebuts Misleading Statements Made by Hungarian Competitor
11. Sangamo BioSciences Provides Update on Phase 1 Safety Trial of SB-728-T for HIV/AIDS
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... 2014 Histogen, Inc., a regenerative medicine ... grown under simulated embryonic conditions, today announced that they ... Medical, Inc. for physician-dispensed aesthetic products containing Histogen’s proprietary ... agreement is an amendment to the existing license between ...
(Date:1/14/2014)... 14, 2014 EquitiesIQ, a leading informational ... ALQA). Alliqua is an emerging biomedical company acquiring, developing, ... care market. , Free report download: http://equitiesiq.com/reports/alliqua/ ... seasoned management team and Board, which launched the company’s ...
(Date:1/14/2014)... iLab Solutions, the leader in core facility management software, today ... In this role, Michelle will work with current and potential ... development of iLab products. Her main goal will be to ... scientific community by offering the most advanced, user-friendly, and high-impact ...
(Date:1/14/2014)... January 14, 2014 Global Record ... innovative information technology solutions for patients, physicians, the ... stakeholders, announced today the signing of a three-year ... and Drug Administration (FDA). This initiative is ...
Breaking Biology Technology:Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 2Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 3EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3iLab Solutions Announces Michelle Detwiler as the New Director of Product Strategy 2Global Record Systems Announces Research Collaboration Agreement with FDA to Create a Novel “Big Data” Paradigm for Collection of Patient Safety and Outcomes Information 2
... today announced the addition of two new members to ... , ,The Madison-based media communications company hopes to broaden ... board of directors with the appointments. Peercy and Weis ... at which time they will stand for election. , ...
... and creators of corporate intranets are frustrated. In a ... Internet was their primary information resource at work, but ... main source of information. Given all the money and ... users find so little value in them? , ,By ...
... million incentive package announced today from the state of ... announced that it will build a new $85 million ... Gov. Jim Doyles financial package is intended to assist ... , ,The new 475,000-square-foot facility will house the companys ...
Cached Biology Technology:The unfilled promise of corporate intranets 2The unfilled promise of corporate intranets 3GE Healthcare gets $7 million package from governor to stay in state 2
(Date:4/23/2014)... early fetal death according to a new study by ... Los Angeles and Ulaanbaatar, Mongolia the coldest capital ... today in the journal BMC Pregnancy and Childbirth ... ambient air pollutants and pregnancy loss in Ulaanbaatar (UB), ... levels of air pollution of all world capitals, with ...
(Date:4/23/2014)... the Indiana University School of Public Health-Bloomington has bolstered ... by finding a strong association between heme iron, found ... , The study found that heme iron consumption increased ... while no association was found between nonheme iron, which ... heart disease. , The study was published online ahead ...
(Date:4/23/2014)... in their mid-thirties and forties, face a devastating ... two decades. "Mutant" protein clusters, long blamed for ... the primary focus of therapies in development by ... Prof. Gerardo Lederkremer and Dr. Julia Leitman of ... Immunology, in collaboration with Prof. Ulrich Hartl of ...
Breaking Biology News(10 mins):Pollutants from coal-burning stoves strongly associated with miscarriages in Mongolia 2Study: Iron consumption can increase risk for heart disease 2On the defensive 2On the defensive 3
... CAMDEN When kitchens become infiltrated with fruit flies, especially ... the flying pests would just turn to ice. The ... genetic system making it an ideal organism to test a ... Shutting off this molecular thermostat could result in a newfound ...
... workshop is designed to provide students with an insight ... Geographic Society (NGS). It will feature an overview ... exploration for NGS; information from Rebecca Martin, director of ... grant recipients; and a panel discussion including NGS Emerging ...
... Pablo Sobrado, assistant professor of biochemistry with the Fralin Life ... grant from the National Science Foundation (NSF) to advance his ... mycobacteria. Iron is essential for all life. The ... Aspergillus fumigatus and Mycobacterium tuberculosis need. To ...
Cached Biology News:Frozen flies may yield secrets for human organ transplants 2Research targets basic metabolism of disease-causing fungi, bacteria 2
Anti-Ephrin B1 Host: rabbit polyclonal Species Reactivity: human Applications: WB Storage: 4C...
Human Regulatory T cell Staining Kit #2 (w/ APC Foxp3 PCH101, FITC CD4, PE CD25)...
...
Request Info...
Biology Products: